|
key focus areas – Innovation
The key to progress for life sciences companies such as MDS is innovation. It is the source of new opportunities. MDS has a track record of being at the forefront of innovation, and continues to make significant R&D investments to fuel our innovation engine.
Mass-Spectrometry Software
MDS Analytical Technologies’ Analyst® 1.5 software, which runs our mass-spectrometry systems, allows researchers to screen more analytes with greater accuracy and precision. This will serve the food and environmental industries as they will now be able to screen for more than 600 contaminants in a single run.
ECLA Testing
MDS Pharma Services now offers its bioanalysis clients the benefits of electrochemilumiscent assay (ECLA) testing at its laboratory in Montreal.
Vital Research
MDS Nordion has established a Molecular Imaging Centre of Excellence to advance cardiology research at the University of Ottawa Heart Institute.
|